Lyophilized Sterile Vial
Tested: 99.4% (CJC) / 99.5% (Ipam)
Current Lot: MV-2026-TON10-03
Multi-Peptide Precision Synergy
Tone Metabolic Secretagogue Blend (CJC-1295 + Ipamorelin)
10mg / 5mL (5mg CJC / 5mg Ipamorelin) • HPLC Purity: 99.4% (CJC) / 99.5% (Ipam) • Target: ≥ 99.0% per component
Dual secretagogue synergy combining GHRH analog (CJC-1295 No DAC) with GHSR-1a agonist (Ipamorelin) to investigate physiological amplification of pulsatile growth hormone release.
Wholesale Commercial Pricing
Verified Provider Portal Required
• No consumer checkout • Tiered volume schedules • Certificate included with shipment
Formula Dual Secretagogue Matrix
Molecular Weight Co-Lyophilized Matrix
CAS Registry # 863288-34-0 / 170851-70-4
Peptide Sequence / Structure CJC-1295 No DAC (5mg) + Ipamorelin (5mg)
Current Lot Verification
Historical Lot Archive → Lot #MV-2026-TON10-03 Analytical Results
Independent laboratory testing panel for active distribution batch.
| Analysis Category | Reported Result | Analytical Method | Verification Status |
|---|---|---|---|
| CJC-1295 Content & Purity | 5.04 mg (99.4%) | RP-HPLC | Conforms |
| Ipamorelin Content & Purity | 5.02 mg (99.5%) | RP-HPLC | Conforms |
| Endotoxin | < 0.05 EU/mg | LAL Kinetic | Conforms |
Biological Mechanism of Action
Simultaneous GHRH receptor stimulation (adenylate cyclase/cAMP) and GHSR activation (phospholipase C/IP3) results in synergistic somatotrope degranulation without cortisol elevation.
Research Focus Areas: Dual Secretagogue Pulsatile Amplification Somatotrope Synergy
Scientific Literature Cross-Reference
Explore primary peer-reviewed papers, PubMed indexes, and pharmacology data for Tone Blend.